Be the Next Game Changer
Medidata: Power Smarter Treatments and Healthier People
Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,900+ customers and partners access the world's most trusted platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systèmes company, is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @medidata.
Our team's mission is to deliver a best-in-class Clinical Trial Financial Management platform by providing differentiated applications, services, and data that tie together the end-to-end process of planning and managing the financial aspects of clinical trials. We are a passionate team of professionals who actively seek opportunities to partner with our clients, industry organizations, sites, and our Medidata colleagues so that we can continue to bring value to our end users and to the patients that we all serve.
Who we are looking for:
We are actively seeking a dynamic and driven Senior Business Analyst who will play a key role in our Clinical Trial Financial Management team.
Although it is possible to recruit a young graduate if the team situation so allows, it is preferable to take on an applicant with 3 to 5 years previous experience in this domain or on an ERP (Enterprise Resource Planning) (configuration and set up, not merely as a user) .
MDSOL Europe Ltd is an equal opportunity employer. We welcome all applications irrespective of race, gender, gender reassignment, age, religion or belief, relationship status, pregnancy/maternity, sexual orientation or disability.
MEDIDATA generates the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes.